Kim Hyena, Kulshreshtha Ambar, Alonso Alvaro, Goldstein Felicia C, Johnson Erik Cb, Gold Matthew E, Quyyumi Arshed A, Lah James J
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Department of Family and Preventive Medicine, Emory School of Medicine, Atlanta, GA, USA.
J Alzheimers Dis. 2025 Jun;105(3):729-735. doi: 10.1177/13872877251331235. Epub 2025 Apr 21.
We examined the association between arterial stiffness using non-invasive pulse wave velocity (PWV) and cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarkers. We conducted a cross-sectional multivariate logistic regression analysis using established cut-off values for PWV and CSF biomarkers. Of the 739 participants, 69% were female, 84% were White, 12% were Black, and the mean age was 62. After adjustment for potential confounders, participants with high PWV had 94% (OR = 1.94, 95% CI 1.20-3.20) greater odds of AD biomarker positivity for tTau/Aβ and 108% (OR = 2.08, 95% Cl, 1.27-3.46) for pTau181/Aβ. Our results suggest that higher arterial stiffness is associated with AD CSF biomarker positivity.
我们研究了使用无创脉搏波速度(PWV)测量的动脉僵硬度与脑脊液(CSF)阿尔茨海默病(AD)生物标志物之间的关联。我们使用PWV和CSF生物标志物的既定临界值进行了横断面多变量逻辑回归分析。在739名参与者中,69%为女性,84%为白人,12%为黑人,平均年龄为62岁。在对潜在混杂因素进行调整后,PWV较高的参与者中tTau/Aβ的AD生物标志物阳性几率高94%(OR = 1.94,95%CI 1.20 - 3.20),pTau181/Aβ的阳性几率高108%(OR = 2.08,95%Cl,1.27 - 3.46)。我们的结果表明,较高的动脉僵硬度与AD脑脊液生物标志物阳性有关。